Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Chella

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Clinical Lung Cancer|May 10, 2024
A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR MutationsIacopo Petrini, Rossella Bruno, Iosè Di Stefano, et al.
Pathologica|November 17, 2025
A tough NUT carcinoma to crackAlessandra Celi, Rossella Bruno, Paola Vignali, et al.
Oncotarget|November 12, 2016
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosisRossella Bruno, Greta Alì, Riccardo Giannini, et al.
Oncology Letters|March 20, 2015
Response to erlotinib in a patient with lung adenocarcinoma harbouring the <i>EML4-ALK</i> translocation: A case reportGreta Alì, Antonio Chella, Cristiana Lupi, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|July 21, 2017
A Human-Humanoid Interaction Through the Use of BCI for Locked-In ALS Patients Using Neuro-Biological Feedback FusionRosario Sorbello, Salvatore Tramonte, Marcello Emanuele Giardina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcomeAntonio Marchetti, Fabio Barassi, Carla Martella, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2017
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experienceMarcello Carlo Ambrogi, Pietro Bertoglio, Vittorio Aprile, et al.
BMC Cancer|May 2, 2019
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case reportMarzia Del Re, Eleonora Rofi, Carla Cappelli, et al.
Cancer Research|May 1, 2002
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patientsAntonio Marchetti, Nicola Tinari, Fiamma Buttitta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesotheliomaAlfonso Cristaudo, Alessandra Bonotti, Silvia Simonini, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Clinical Lung Cancer|May 10, 2024
A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR MutationsIacopo Petrini, Rossella Bruno, Iosè Di Stefano, et al.
Pathologica|November 17, 2025
A tough NUT carcinoma to crackAlessandra Celi, Rossella Bruno, Paola Vignali, et al.
Oncotarget|November 12, 2016
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosisRossella Bruno, Greta Alì, Riccardo Giannini, et al.
Oncology Letters|March 20, 2015
Response to erlotinib in a patient with lung adenocarcinoma harbouring the <i>EML4-ALK</i> translocation: A case reportGreta Alì, Antonio Chella, Cristiana Lupi, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|July 21, 2017
A Human-Humanoid Interaction Through the Use of BCI for Locked-In ALS Patients Using Neuro-Biological Feedback FusionRosario Sorbello, Salvatore Tramonte, Marcello Emanuele Giardina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcomeAntonio Marchetti, Fabio Barassi, Carla Martella, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2017
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experienceMarcello Carlo Ambrogi, Pietro Bertoglio, Vittorio Aprile, et al.
BMC Cancer|May 2, 2019
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case reportMarzia Del Re, Eleonora Rofi, Carla Cappelli, et al.
Cancer Research|May 1, 2002
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patientsAntonio Marchetti, Nicola Tinari, Fiamma Buttitta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesotheliomaAlfonso Cristaudo, Alessandra Bonotti, Silvia Simonini, et al.
Pageof 12